These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21849666)

  • 1. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy.
    Tedesco FS; Hoshiya H; D'Antona G; Gerli MF; Messina G; Antonini S; Tonlorenzi R; Benedetti S; Berghella L; Torrente Y; Kazuki Y; Bottinelli R; Oshimura M; Cossu G
    Sci Transl Med; 2011 Aug; 3(96):96ra78. PubMed ID: 21849666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.
    Benedetti S; Uno N; Hoshiya H; Ragazzi M; Ferrari G; Kazuki Y; Moyle LA; Tonlorenzi R; Lombardo A; Chaouch S; Mouly V; Moore M; Popplewell L; Kazuki K; Katoh M; Naldini L; Dickson G; Messina G; Oshimura M; Cossu G; Tedesco FS
    EMBO Mol Med; 2018 Feb; 10(2):254-275. PubMed ID: 29242210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete genetic correction of ips cells from Duchenne muscular dystrophy.
    Kazuki Y; Hiratsuka M; Takiguchi M; Osaki M; Kajitani N; Hoshiya H; Hiramatsu K; Yoshino T; Kazuki K; Ishihara C; Takehara S; Higaki K; Nakagawa M; Takahashi K; Yamanaka S; Oshimura M
    Mol Ther; 2010 Feb; 18(2):386-93. PubMed ID: 19997091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model.
    Hiramuki Y; Abe S; Uno N; Kazuki K; Takata S; Miyamoto H; Takayama H; Morimoto K; Takehara S; Osaki M; Tanihata J; Takeda S; Tomizuka K; Oshimura M; Kazuki Y
    Sci Rep; 2023 Mar; 13(1):4360. PubMed ID: 36928364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
    Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
    Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene.
    Hoshiya H; Kazuki Y; Abe S; Takiguchi M; Kajitani N; Watanabe Y; Yoshino T; Shirayoshi Y; Higaki K; Messina G; Cossu G; Oshimura M
    Mol Ther; 2009 Feb; 17(2):309-17. PubMed ID: 19034264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Challenge toward gene-therapy using iPS cells for Duchenne muscular dystrophy].
    Oshimura M; Kazuki Y; Uno N
    Rinsho Shinkeigaku; 2012; 52(11):1139-42. PubMed ID: 23196542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene.
    Koppanati BM; Li J; Reay DP; Wang B; Daood M; Zheng H; Xiao X; Watchko JF; Clemens PR
    Gene Ther; 2010 Nov; 17(11):1355-62. PubMed ID: 20535217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
    Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
    Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
    Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
    Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
    Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy for muscular dystrophy].
    Takeda S
    No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice.
    Su X; Shen Y; Jin Y; Jiang M; Weintraub N; Tang Y
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
    Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice].
    Li HH; Zhang SM; Fang SY; Chen CL; Luo YD; Guan Y; Wang DW; Xiao X
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1513-6. PubMed ID: 14521733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.